Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Statement re Orimulsion

5 Oct 2006 10:27

Quadrise Fuels International PLC05 October 2006 5 October 2006 Quadrise Fuels International plc ("Quadrise" or "the Company") Statement re Orimulsion(R) Quadrise Fuels International plc (AIM: QFI) has noted the recent statement madeby Venezuela's Ministry of Energy and Petroleum regarding the termination of theuse of Venezuela's extra-heavy crude to produce Orimulsion(R), the firstemulsified fuel available to worldwide markets, and the cessation of productionof Orimulsion(R) by the end of 2006 by Sinovensa, the joint venture businessbetween China National Petroleum Corporation and Petroleos de Venezuela SA("PDVSA"). Full details can be recovered from the PDVSA web site www.pdvsa.com. As previously anticipated, this development now leaves Quadrise as the onlypotential provider of bulk quantity oil in water emulsion fuel through themarketing and manufacture of MSAR(R) fuel in the exclusive territory in which itoperates under its licence agreement with Akzo Nobel. This territory covers allcountries excluding Canada, Mexico, the United States, Japan and the PeoplesRepublic of China. In the United States, Quadrise operates through its associatecompany Quadrise Fuels US LP, in which it has a 50% interest. Commenting on this development, Bill Howe, Chief Executive Officer of Quadrise,commented: "Quadrise now has the added opportunity to actively engage with existingOrimulsion(R) customers with a view to developing new production bases for MSAR(R) fuel. This opportunity arises at a time when we are actively progressingagreements to source refinery residue feedstock in our chosen target marketswhere high quantities of oil fired power generation capacity exist. Our currentstudies suggest a strong synergy between oil refiners and power generators whereQuadrise can act as a sink for uncut, refinery vacuum residues." MSAR(R), a second generation emulsion fuel, has the following advantages overOrimulsion(R): • MSAR(R) is a more finely dispersed emulsion and achieves a superior carbon burnout.• MSAR(R) can be produced using feedstock from a variety of sources allowing flexible multi-sourcing and on-site manufacture.• MSAR(R) can be manufactured to customer specification (eg low sulphur). For further information, please contact: Quadrise Fuels InternationalBill HoweCEOT: +44 (0)20 7550 4930 Smith & Williamson Corporate Finance LimitedAzhic Basirov+44 (0)20 7131 4000 Parkgreen CommunicationsSimon Robinson /Victoria Thomas+44 (0)20 7493 3713 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20218:00 amEQSEdison Investment Research Limited: Quadrise Fuels International (QFI): Cleaner fuel, cleaner planet
26th Nov 20213:30 pmRNSResult of AGM
26th Nov 20217:00 amRNSAGM Statement
1st Nov 20215:00 pmRNSPosting of Annual Report and Notice of AGM
20th Oct 20215:45 pmRNSMorocco Travel Restrictions
5th Oct 20214:41 pmRNSSecond Price Monitoring Extn
5th Oct 20214:35 pmRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSFinal Results, Directorate Change & Notice of AGM
1st Oct 20217:00 amRNSTotal Voting Rights
24th Sep 20217:00 amRNSNotice of Results and Investor Presentation
23rd Sep 20217:00 amRNSUtah Project Update
20th Sep 20214:36 pmRNSPrice Monitoring Extension
3rd Sep 20212:30 pmRNSIssue of Share Options & Director/PDMR Dealing
2nd Sep 20214:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSPublication of bioMSAR Test Results
23rd Aug 20217:00 amRNSGreenfield Commercial Trial Agreement Extension
11th Aug 20217:00 amRNSUpdate on bioMSAR™ Testing
4th Aug 20217:00 amRNSUtah Project Update
30th Jul 20219:30 amRNSBlock Admissions
16th Jul 20214:40 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
16th Jul 20211:15 pmRNSDirectorate Change
28th Jun 20217:00 amRNSUpdate on bioMSAR™ and MSAR® projects
17th May 20214:40 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
4th May 20219:24 amRNSIssue of Equity
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
16th Apr 20214:40 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
1st Apr 202112:50 pmRNSUpdate re Greenfield Commercial Trial Agreement
29th Mar 20217:00 amRNSInterim Results
25th Mar 20214:40 pmRNSSecond Price Monitoring Extn
25th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSResults of Open Offer
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSResults of Placing and Open Offer Launch
1st Mar 20214:41 pmRNSProposed Placing and Open Offer
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSFinal Issue of Convertible Securities
4th Feb 20214:41 pmRNSSecond Price Monitoring Extn
4th Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.